Anesthesia Intraoral Module (AIM)
Direct Pharyngeal Oxygenation
Non-OR Anesthesia (NORA) case volume and complexity continue to increase. AIM replaces fragmented airway tasks – oxygenation, capnography, neck-strapped bite blocks, and airway rescue – into an optimized airway platform. AIM reduces hypoxic events, procedural interruptions and delays, and staff distractions.
FDA-Cleared, Anesthesiologist-Designed, USA-Manufactured
Oxygen Powerhouse
AIM delivers oxygen near the tracheal inlet, minimizing air dilution, with pulmonary FiO2 of 96% and higher (FDA designated, third-party lab tested).
AIM does not cause gag-reflex, facilitating pre-oxygenation in high-risk patients before sedation, all the way through recovery.
AIM Vs. High Flow Nasal Cannula (HFNC)
AIM rivals HFNC-level oxygenation—at a fraction of the cost and complexity.
A recent study from Baylor University demonstrated pharyngeal oxygen delivery at 10 l/min superior to the HFNC at 60 l/min in a manikin model.
Continuous Capnography
Capnography is a required monitor, per ASA sedation guidelines. AIM captures pharyngeal carbon dioxide with continuous end-tidal CO2 monitoring. An early alert can prevent a hypoxic event in remote hospital settings.
Single-Step Oral Airway Placement
Oral airway placement for upper airway obstruction is a rushed, multi-step process (remove oxygen source, pry the jaw open, place oral airway, replace ooxygen source).
With ongoing oxygenation and open mouth, an oral airway is inserted, without procedural interruptions.
Seamless Conversion to General Anesthesia
Emergent conversion to general anesthesia may become necessary (excessive patient movement, extreme pain or impending respiratory failure).
With ongoing oxygenation and open mouth, AIM replaces rushed, injury-prone maneuvers with quick placement of an LMA or an ET tube.
Eliminates Bite-blocks
With an integrated bite block, AIM eliminates neck-strapped bite blocks, improving patient comfort while reducing exposure to contaminated objects and medical waste disposal.
Awake Fiberoptic Intubation
AIM may facilitate awake fiberoptic intubation by eliminating the pink-airway, improving patient comfort, while superior pharyngeal oxygenation lowers desaturation risk.
AIM may be reintroduced before extubation to ensure high FiO₂ for a safer transition to spontaneous ventilation.
May Lower the Risk of Airway Fires
Nasal cannulas and face masks accumulate oxygen around the face (oxygen is heavier than air), risking airway fires and malpractice lawsuits.
AIM’s targeted pharyngeal oxygenation may reduce airway fires.
Small Size, Big Impact
High oxygen delivery, reliable capnography, single-step airway resuscitation and seamless conversion to general anesthesia make AIM an ideal device for a broad range of NORA procedures.
Lower Environmental Impact
Due to it’s compact size, AIM consumes fewer manufacturing resources.
Additionally, by eliminating the need for EGD bite-blocks and awake fiberoptic intubation (pink airways), AIM further lowers disposable consumption.
Manufactured in the USA
With a focus on manufacturing the highest quality medical device, manufacturing, and packaging is done here in the US.
No overseas containers, and no supply chain issues.